Caribou Biosciences (CRBU) Competitors $2.43 +0.09 (+3.85%) Closing price 04:00 PM EasternExtended Trading$2.39 -0.04 (-1.65%) As of 06:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CRBU vs. KURA, NBTX, NAGE, SEPN, OCS, IOVA, VIR, GHRS, AVXL, and PROKShould you be buying Caribou Biosciences stock or one of its competitors? The main competitors of Caribou Biosciences include Kura Oncology (KURA), Nanobiotix (NBTX), Niagen Bioscience (NAGE), Septerna (SEPN), Oculis (OCS), Iovance Biotherapeutics (IOVA), Vir Biotechnology (VIR), GH Research (GHRS), Anavex Life Sciences (AVXL), and ProKidney (PROK). These companies are all part of the "pharmaceutical products" industry. Caribou Biosciences vs. Its Competitors Kura Oncology Nanobiotix Niagen Bioscience Septerna Oculis Iovance Biotherapeutics Vir Biotechnology GH Research Anavex Life Sciences ProKidney Caribou Biosciences (NASDAQ:CRBU) and Kura Oncology (NASDAQ:KURA) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, profitability, institutional ownership, earnings, risk, valuation, analyst recommendations and dividends. Does the media prefer CRBU or KURA? In the previous week, Kura Oncology had 7 more articles in the media than Caribou Biosciences. MarketBeat recorded 7 mentions for Kura Oncology and 0 mentions for Caribou Biosciences. Kura Oncology's average media sentiment score of 0.48 beat Caribou Biosciences' score of 0.00 indicating that Kura Oncology is being referred to more favorably in the news media. Company Overall Sentiment Caribou Biosciences Neutral Kura Oncology Neutral Which has more risk & volatility, CRBU or KURA? Caribou Biosciences has a beta of 2.59, indicating that its share price is 159% more volatile than the S&P 500. Comparatively, Kura Oncology has a beta of 0.32, indicating that its share price is 68% less volatile than the S&P 500. Do institutionals and insiders have more ownership in CRBU or KURA? 77.5% of Caribou Biosciences shares are held by institutional investors. 9.5% of Caribou Biosciences shares are held by company insiders. Comparatively, 6.4% of Kura Oncology shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Do analysts prefer CRBU or KURA? Caribou Biosciences presently has a consensus target price of $6.67, suggesting a potential upside of 174.35%. Kura Oncology has a consensus target price of $24.10, suggesting a potential upside of 155.57%. Given Caribou Biosciences' higher probable upside, analysts clearly believe Caribou Biosciences is more favorable than Kura Oncology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Caribou Biosciences 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50Kura Oncology 1 Sell rating(s) 4 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 2.69 Which has preferable valuation & earnings, CRBU or KURA? Caribou Biosciences has higher earnings, but lower revenue than Kura Oncology. Kura Oncology is trading at a lower price-to-earnings ratio than Caribou Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCaribou Biosciences$9.99M22.65-$149.10M-$1.78-1.37Kura Oncology$83.28M9.83-$173.98M-$2.26-4.17 Is CRBU or KURA more profitable? Kura Oncology has a net margin of 0.00% compared to Caribou Biosciences' net margin of -1,800.93%. Kura Oncology's return on equity of -52.32% beat Caribou Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Caribou Biosciences-1,800.93% -62.35% -49.65% Kura Oncology N/A -52.32%-29.59% SummaryKura Oncology beats Caribou Biosciences on 9 of the 17 factors compared between the two stocks. Get Caribou Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CRBU and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRBU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRBU vs. The Competition Export to ExcelMetricCaribou BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$226.28M$3.32B$6.10B$10.53BDividend YieldN/A2.29%5.51%4.67%P/E Ratio-1.3721.5485.6826.86Price / Sales22.65428.10583.23185.42Price / CashN/A46.3226.3031.10Price / Book0.8710.0613.256.72Net Income-$149.10M-$52.22M$3.30B$276.44M7 Day Performance4.29%5.84%4.70%3.13%1 Month Performance29.95%12.04%8.43%10.21%1 Year Performance33.52%26.13%88.01%40.35% Caribou Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRBUCaribou Biosciences1.8994 of 5 stars$2.43+3.8%$6.67+174.3%+25.1%$226.28M$9.99M-1.37100KURAKura Oncology3.9746 of 5 stars$8.97-0.9%$24.10+168.7%-45.7%$785.52M$53.88M-3.97130NBTXNanobiotix1.2698 of 5 stars$18.02+11.0%$11.00-39.0%+338.9%$778.60M$39.18M0.00100Analyst RevisionGap DownHigh Trading VolumeNAGENiagen Bioscience2.9416 of 5 stars$9.90+1.4%$13.42+35.6%N/A$778.39M$99.60M47.15120SEPNSepterna1.3312 of 5 stars$18.15+4.0%$26.75+47.4%N/A$778.01M$1.08M-1.80N/AOCSOculis2.8244 of 5 stars$17.54-0.5%$35.75+103.8%+40.6%$769.76MN/A-6.572Trending NewsAnalyst ForecastIOVAIovance Biotherapeutics4.5745 of 5 stars$2.23+5.7%$11.90+433.6%-78.9%$763.51M$164.07M-1.81500News CoverageVIRVir Biotechnology3.541 of 5 stars$5.63+2.6%$17.30+207.3%-27.8%$762.65M$74.21M-1.41580News CoverageGHRSGH Research2.0984 of 5 stars$14.53+0.6%$32.00+120.2%+101.2%$751.29MN/A-19.6310AVXLAnavex Life Sciences3.793 of 5 stars$8.65-0.1%$44.00+408.7%+71.8%$743.84MN/A-15.1840Analyst ForecastPROKProKidney2.7301 of 5 stars$2.48-0.4%$6.25+152.0%+71.1%$732.76M$527K-4.353 Related Companies and Tools Related Companies Kura Oncology Competitors Nanobiotix Competitors Niagen Bioscience Competitors Septerna Competitors Oculis Competitors Iovance Biotherapeutics Competitors Vir Biotechnology Competitors GH Research Competitors Anavex Life Sciences Competitors ProKidney Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CRBU) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Caribou Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Caribou Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
